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occurred around the world. Firm evi-
dence indicates that the ﬁ  fth and sixth 
cholera pandemics were caused by the 
classical biotype whereas the most ex-
tensive and ongoing seventh pandemic 
is caused by the El Tor biotype. Since 
the onset of El Tor dominance in 1961, 
the classical strains have been gradu-
ally replaced by the El Tor strains and 
are now believed to be extinct. How-
ever, reports from Bangladesh (6), 
Mozambique (7), and this study have 
provided sufﬁ  cient evidence to indi-
cate that the classical cholera toxin 
gene has reappeared but that for these 
cases its carrier has been El Tor. Al-
though how the classical cholera toxin 
in El Tor strains would affect V. chol-
erae pathogenicity is unclear, cholera 
caused by the classical biotype is more 
severe, whereas the El Tor biotype is 
considered to be better able to sur-
vive in the environment (1,9). Given 
that cholera toxin is directly respon-
sible for the major clinical sign of the 
disease, such a genetic change could 
result in substantial alteration in the 
clinical manifestation of cholera. Ad-
ditionally, this subtle genetic change 
may also inﬂ  uence the effectiveness of 
current cholera vaccines, which could 
stimulate both antitoxic and antibacte-
rial immunity.
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Mycobacterium 
avium subsp. 
hominissuis 
Infection in 2 Pet 
Dogs, Germany
To the Editor: The genus Myco-
bacterium contains various obligate 
and opportunistic pathogens of ani-
mals, which may also be transmitted 
to humans and cause disease in, thus 
exhibiting a considerable zoonotic 
potential (1,2). During the past few 
decades, members of the Mycobac-
terium avium-intracellulare complex 
(MAIC) emerged as pathogens of hu-
man diseases, including lymphadeni-
tis in children, pulmonary tubercu-
losis-like disease, and disseminated 
infections (occurring predominantly 
in immunocompromised persons, par-
ticularly AIDS patients) (1,2). Simi-
larly, important animal diseases are 
caused by members of this group, e.g., 
avian tuberculosis and paratuberculo-
sis in ruminants (1). MAIC includes 
M. intracellulare and 4 subspecies of 
M. avium, namely, M. avium subsp.
avium, M. avium subsp. hominissuis, 
M. avium subsp. silvaticum, and M. 
avium subsp. paratuberculosis ( 3,4). 
Whereas members of the M. tuber-
culosis complex are transmitted by 
direct host contact, MAIC species are 
acquired predominantly from environ-
mental sources, including soil, water, 
dust, and feed. Subclinical infections 
are common among birds (1,2).
M. avium strains differ from M. 
intracellulare by containing the in-
sertion sequence (IS) IS1245 (3) and 
are further discriminated by terms of 
IS901 ( 4). Avian isolates (M. avium 
subsp. avium) are usually positive for 
IS901 and represent the main pathogen 
of avian tuberculosis (5). In contrast, 
mammalian isolates are IS901-negative 
and have been designated as M. avium 
subsp. hominissuis because of their pre-
dominant hosts. This subspecies is only 
weakly virulent for birds but causes 
disease in animals and humans (5).
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Even though M. tuberculosis and 
M. bovis are the common etiologic 
agents of canine mycobacteriosis, 
dogs are reported to be relatively resis-
tant to M. avium infection (6,7). None-
theless, sporadic cases usually show 
nonspeciﬁ   c clinical signs, whereas 
necropsy consistently reveals granu-
lomatous inﬂ   ammation in numerous 
organs, including lymph nodes, intes-
tine, spleen, liver, lung, bone marrow, 
and even spinal cord (7,8). The pre-
dominant involvement of the gastro-
intestinal tract indicates an oral route 
of infection (7,8), and simultaneously 
increases the risk for human infection 
by fecal spread of mycobacteria.
Our report concerns 2 young 
dogs, a 3-year-old miniature schnau-
zer and a 1-year-old Yorkshire ter-
rier, that lived in different geographic 
regions in Germany. Both had had 
therapy-resistant fever, lethargy, pro-
gressive weight loss, and generalized 
lymphadenomegaly for several weeks 
and were euthanized after a ﬁ  nal 
phase of diarrhea. Necropsy ﬁ  ndings, 
similar in both dogs, included gener-
alized enlargement of lymph nodes 
with a whitish, granular to greasy cut 
surface, leading to intraabdominal ad-
hesions by extensive involvement of 
mesenteric lymph nodes. In the ter-
rier, the greater omentum and a part 
of the right apical lung lobe showed 
changes similar to those in the lymph 
nodes. Furthermore, numerous white 
1-mm nodules were found in the 
spleen (both dogs), liver (schnauzer) 
and costal pleura (terrier). 
Histologic examination showed 
(pyo-)granulomatous inﬂ  ammation 
of lymph nodes, tonsils, liver, spleen, 
and greater omentum. Additionally, 
pyogranulomatous pleuropneumonia 
was present in the terrier, and a granu-
lomatous enteritis and pyelitis in the 
schnauzer. The granulomatous lesions 
frequently exhibited central necrosis 
surrounded by macrophages, epithel-
oid cells, and few neutrophils (Figure, 
panel A). However, multinucleated gi-
ant cells or mineralization was not ob-
served. In both animals, Ziehl-Neelsen 
stain demonstrated large numbers of 
acid-fast bacilli within macrophages 
(Figure, panel B). Samples of lymph 
nodes and lung were processed for 
mycobacterial culture by using stan-
dard procedures (Löwenstein-Jensen, 
Stonebrink medium). Colonies emerg-
ing after 2-week incubation at 37°C 
were investigated by PCR targeting 
IS1245 and IS901 (3,4). In all sam-
ples, M. avium subsp. hominissuis was 
identiﬁ  ed by growth characteristics as 
well as presence of an IS1245-speciﬁ  c 
and absence of an IS901-speciﬁ  c PCR 
product. Additionally, sequencing of 
hsp65 was conducted (9), which in-
dicated M. avium subsp. hominissuis 
in both dogs (GenBank accession nos. 
EU488724 and EU488725).
Despite improved therapeutic ap-
proaches, MAIC infection represents 
a frequent bacterial complication in 
persons with AIDS. However, several 
studies showed a very low incidence 
of M. avium subsp. avium infections in 
humans. Thus, most of these HIV-relat-
ed infections are attributed to M. avium 
subsp. hominissuis (2,5). Unfortunate-
ly, the subspecies of M. avium was not 
identiﬁ  ed in most canine cases reported 
in the literature (7,8). Nonetheless, 
different serotypes of M. avium, cor-
responding to either M. avium subsp. 
avium or M.  avium subsp. hominis-
suis, have been identiﬁ  ed sporadically 
(6,10). The source and route of infec-
tion were unclear in all reports includ-
ing ours, albeit repeatedly observed en-
teritis strongly suggested an oral mode 
of infection. A common environmental 
or wildlife reservoir represents the most 
probable source of M. avium infection 
for both humans and animals. Howev-
er, there is also evidence of direct trans-
mission (1–3). Therefore, M. avium 
subsp.  hominissuis infection in dogs 
may comprise a considerable zoonotic 
potential, particularly if pet dogs with 
close contact to the owner are affected 
and if prolonged nonspeciﬁ  c  clinical 
signs and intestinal involvement occur, 
as demonstrated here.
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Figure. A) Mesenteric lymph node of Yorkshire Terrier shows diffuse granulomatous 
lymphadenitis with extensive inﬁ   ltration of macrophages, foci of pyogranulomatous 
inﬂ   ammation (arrowhead), and focal necrosis (asterisk). Hematoxylin and eosin stain; scale 
bar represents 100 μm. B) Retropharyngeal lymph node of schnauzer shows innumerable 
acid-fast bacilli (arrows) within the cytoplasm of macrophages. Ziehl-Neelsen stain; scale 
bar represents 25 μm.LETTERS
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Serogroup Y 
Meningococcal 
Disease, Colombia
To the Editor:  Neisseria men-
ingitidis is the etiologic agent of out-
breaks, epidemics, and sporadic cases 
of meningitis or meningococcemia. 
Such infections have high illness and 
death rates, especially in children <5 
years of age and adolescents. N. men-
ingitidis serogroups A, B, C, Y, and 
W135 cause most meningococcal dis-
ease worldwide (1).
In Colombia, public health no-
tiﬁ  cation is required for all cases of 
invasive meningococcal disease. This 
reporting system is supported by a 
laboratory-based surveillance network 
for acute bacterial meningitis that has 
been coordinated by the Microbiol-
ogy Group at the Instituto Nacional de 
Salud since 1994 (2,3). Clinical labo-
ratories in Colombia submit isolates 
with associated information including 
geographic origin, specimen source, 
age, sex, and clinical diagnosis of the 
patient. Identiﬁ  cation is conﬁ  rmed by 
traditional phenotypic methods (4). 
Isolates are serogrouped by agglutina-
tion using commercial antisera (Difco, 
Detroit, MI, USA, and Becton Dick-
inson, Franklin Lakes, NJ, USA) and 
subtyped by dot blot with monoclo-
nal antibodies (RIVM, Bilthoven, the 
Netherlands; and Institute Adolfo Lutz 
[IAL], São Paulo, Brazil) (5). Antimi-
crobial drug susceptibility testing for 
penicillin and rifampin is performed 
by the agar dilution, according to Clin-
ical and Laboratory Standards Institute 
methods (6); for the breakpoints, we 
used those recommended by the Mesa 
Española de Normalización de la Sen-
sibilidad y Resistencia a los Antimi-
crobianos (MENSURA) group (7). 
The reference laboratory participates 
in an external quality assurance pro-
gram coordinated by the Pan Ameri-
can Health Organization (Sistema 
Regional de Vacunas [SIREVA] II, 
PAHO, Washington, DC, USA) with 
the Carlos III Institute, Madrid, Spain, 
and the IAL.
From 1994 through 2006, 434 N. 
meningitidis isolates were received by 
the Microbiology Group, from 22 of 
35 departments (political divisions) 
and the Capital District: 119 (27.4%) 
from Antioquia, 117 (27.0%) from 
Bogotá, DC, 72 (16.6%) from Valle, 
25 (5.8%) from Risaralda, 21 (4.8%) 
from Caldas, and 80 (18.4%) from 18 
other departments. Distribution by de-
partment is published at the Institute’s 
website (www.ins.gov.co) (8). Accord-
ing to public health reports, the refer-
ence laboratory is receiving ≈27% of 
the clinical case isolates. A slight 
majority (53.8%) were cultured from 
male patients. The age of patients was 
available for 396 isolates: 254 (64.1%) 
were <1–9 years of age, 71 (17.9%) 
10–19 years, 41 (10.4%) 20–39 years, 
21 (5.3%) 40–59 years, and 9 (2.3%) 
>59 years. Three hundred ninety-two 
isolates (90.3%) were recovered from 
cerebrospinal  ﬂ   uid and 42 (9.7%) 
from blood cultures. The diagnosis for 
420 (96.8%) patients was meningitis; 
11 (2.5%) patients had sepsis or bacte-
remia, and 3 (0.7%) had other invasive 
diseases (pneumonia, encephalopathy, 
or cellulitis).
Serogroup distribution was 338 
(77.9%) group B, 42 (9.7%) group C, 
40 (9.2%) group Y, and 2 (0.5%) group 
W135; 12 isolates were nongroupable. 
There was little annual variation for 
groups B and C, but there was an un-
expected increase in serogroup Y (Fig-
ure), from 0% in 1994 to 50% in 2006. 
When the period 1994–2002 was com-
pared with 2003–2006, this change 
was signiﬁ  cant, increasing from 2.2% 
to 29.5% (p<0.001).
Antimicrobial drug–susceptibil-
ity testing showed that 17% of the 
isolates had intermediate resistance 
to penicillin (MIC 0.125–1.0 μg/mL) 
and 0.5% high resistance (>2.0 μg/
mL); only 1 isolate was resistant to 
rifampin (>4.0 μg/mL). Penicillin re-
sistance was not associated with any 
speciﬁ  c serogroup.
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